Comparison of effects of antihypertensive drugs on heart rate: Changes from baseline by baseline group and over time

American Journal of Hypertension

Volumn 11, Issue 5, 1998, Pages 597-601

  Materson, Barry J ^a,b,d   Reda, Domenic J ^c   Williams, David W ^c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

Atenolol; Captopril; Clonidine; Diltiazem; Heart rate; Hydrochlorothiazide; Hypertension; Placebo; Prazosin

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CLONIDINE; DILTIAZEM; HYDROCHLOROTHIAZIDE; PRAZOSIN;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; HYPERTENSION; MALE; TIME FACTORS;

EID: 0031839811     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00495-0     Document Type: Article

References (17)

1. Gillum RF: The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J 1988; 116:163-174.
2. Palatini P, Julius S: Heart rate and the cardiovascular risk. J Hypertens 1997;15:3-17.
3. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA: Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987;113:1489-1494.
4. Gillman MW, Kannel WB, Belanger A, D'Agostino RB: Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993;125:1148-1154.
5. Materson BJ, Reda DJ, Cushman WC, et al: Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.
6. SAS/STAT User's Guide, Version 6, Vol 1, 2, 4th ed. SAS Institute, Cary, NC, 1989.
7. Materson BJ: Calcium channel blockers: is it time to split the lump? Am J Hypertens 1995;8:325-329.
8. Beere PA, Glagov S, Zarins CK: Experimental atherosclerosis at the carotid bifurcation of the Cynomolgus monkey: localization, compensatory enlargement, and the sparing effect of lowered heart rate. Arterioscler Thromb 1992;12:1245-1253.
9. Gibson RS, Boden WE: Calcium channel antagonists: friend or foe in postinfarction patients? Am J Hypertens 1996;9(12, part 2):172S-176S.
10. Boden WE: Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes: is there a role for calcium channel blockers? Drugs 1996;52(suppl 4):20-30.
11. Pepine CJ. The role of calcium antagonists in ischaemic heart disease. Eur Heart J 1995;16(suppl H):19-24.
12. Mancia G, Bertinieri G, Grassi G, et al: Effects of blood pressure measurement by the doctor on patients blood pressure and heart rate. Lancet 1983;ii:695-697.
13. Mancia G, Zanchetti A: Editors' corner. White-coat hypertension: misnomers, misconceptions and misunderstanding. What should we do next? J Hypertens 1996; 14:1049-1052.
14. Julius S, Schork N, Schork A: Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set. J Cardiovasc Pharmacol 1988;12(suppl 3):S121-S129.
15. Schork NJ, Weder AB, Schork MA, et al: Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Statist Med 1990;9:301-314.
16. Conway J, Lauwers P: Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 1960;21:21-26.
17. Ogilvie RI, Schlieper E: The effect of hydrochlorothiazide on venous reactivity in hypertensive man. Clin Pharm Therap 1970;11:589-594.